DT
PRCT icon

Diversified Trust’s Procept Biorobotics PRCT Stock Holding History

Diversified Trust’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$669K Sell
29,608
-2,375
-7% -$59.5K 0.01% 659
2026
Q1 		$800K Buy
31,983
+1,349
+4% +$38K 0.01% 530
2025
Q4 		$964K Buy
30,634
+14,408
+89% +$478K 0.02% 451
2025
Q3 		$579K Buy
16,226
+4,279
+36% +$195K 0.01% 590
2025
Q2 		$688K Buy
11,947
+4,760
+66% +$269K 0.02% 495
2025
Q1 		$419K Buy
7,187
+2,538
+55% +$173K 0.01% 630
2024
Q4 		$374K Sell
4,649
-1,775
-28% -$152K 0.01% 678
2024
Q3 		$515K Sell
6,424
-5,168
-45% -$367K 0.01% 577
2024
Q2 		$708K Sell
11,592
-1,850
-14% -$110K 0.02% 441
2024
Q1 		$664K Buy
13,442
+2,725
+25% +$130K 0.02% 439
2023
Q4 		$449K Buy
10,717
+1,004
+10% +$34.2K 0.02% 531
2023
Q3 		$319K Buy
+9,713
New +$331K 0.01% 596

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Diversified Trust's PRCT Position: Q2 2026 in Review

Diversified Trust reduced its Procept Biorobotics (PRCT) stake by 7.4% in Q2 2026, selling an estimated $59.5K and leaving 29,608 shares worth $669K. The position accounts for 0.01% of the portfolio, ranked #659.

Diversified Trust first reported a position in PRCT in Q3 2023 and has held it in 12 quarters since. The position peaked at $964K in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Diversified Trust held 29,608 shares of Procept Biorobotics worth $669K as of Q2 2026.
  • Diversified Trust sold 2,375 Procept Biorobotics shares in Q2 2026, an estimated $59.5K.
  • Procept Biorobotics made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #659 holding.
  • Diversified Trust first reported a position in Procept Biorobotics in Q3 2023 and has held it in 12 quarters since.
  • Diversified Trust's Procept Biorobotics position peaked at $964K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.